Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)

dc.contributor.authorKaracin C.
dc.contributor.authorOksuzoglu B.
dc.contributor.authorDemirci A.
dc.contributor.authorKeskinkılıç M.
dc.contributor.authorBaytemür N.K.
dc.contributor.authorYılmaz F.
dc.contributor.authorSelvi O.
dc.contributor.authorErdem D.
dc.contributor.authorAvşar E.
dc.contributor.authorPaksoy N.
dc.contributor.authorDemir N.
dc.contributor.authorGöksu S.S.
dc.contributor.authorTürker S.
dc.contributor.authorBayram E.
dc.contributor.authorÇelebi A.
dc.contributor.authorYılmaz H.
dc.contributor.authorKuzu Ö.F.
dc.contributor.authorKahraman S.
dc.contributor.authorGökmen İ.
dc.contributor.authorSakin A.
dc.contributor.authorAlkan A.
dc.contributor.authorNayır E.
dc.contributor.authorUğraklı M.
dc.contributor.authorAcar Ö.
dc.contributor.authorErtürk İ.
dc.contributor.authorDemir H.
dc.contributor.authorAslan F.
dc.contributor.authorSönmez Ö.
dc.contributor.authorKorkmaz T.
dc.contributor.authorCelayir Ö.M.
dc.contributor.authorKaradağ İ.
dc.contributor.authorKayıkçıoğlu E.
dc.contributor.authorŞakalar T.
dc.contributor.authorÖktem İ.N.
dc.contributor.authorEren T.
dc.contributor.authorErul E.
dc.contributor.authorMocan E.E.
dc.contributor.authorKalkan Z.
dc.contributor.authorYıldırım N.
dc.contributor.authorErgün Y.
dc.contributor.authorAkagündüz B.
dc.contributor.authorKarakaya S.
dc.contributor.authorKut E.
dc.contributor.authorTeker F.
dc.contributor.authorDemirel B.Ç.
dc.contributor.authorKaraboyun K.
dc.contributor.authorAlmuradova E.
dc.contributor.authorÜnal O.Ü.
dc.contributor.authorOyman A.
dc.contributor.authorIşık D.
dc.contributor.authorOkutur K.
dc.contributor.authorÖztosun B.
dc.contributor.authorGülbağcı B.B.
dc.contributor.authorKalender M.E.
dc.contributor.authorŞahin E.
dc.contributor.authorSeyyar M.
dc.contributor.authorÖzdemir Ö.
dc.contributor.authorSelçukbiricik F.
dc.contributor.authorKanıtez M.
dc.contributor.authorDede İ.
dc.contributor.authorGümüş M.
dc.contributor.authorGökmen E.
dc.contributor.authorYaren A.
dc.contributor.authorMenekşe S.
dc.contributor.authorEbinç S.
dc.contributor.authorAksoy S.
dc.contributor.authorİmamoğlu G.İ.
dc.contributor.authorAltınbaş M.
dc.contributor.authorÇetin B.
dc.contributor.authorUluç B.O.
dc.contributor.authorEr Ö.
dc.contributor.authorKaradurmuş N.
dc.contributor.authorErdoğan A.P.
dc.contributor.authorArtaç M.
dc.contributor.authorTanrıverdi Ö.
dc.contributor.authorÇiçin İ.
dc.contributor.authorŞendur M.A.N.
dc.contributor.authorOktay E.
dc.contributor.authorBayoğlu İ.V.
dc.contributor.authorPaydaş S.
dc.contributor.authorAydıner A.
dc.contributor.authorSalim D.K.
dc.contributor.authorGeredeli Ç.
dc.contributor.authorYavuzşen T.
dc.contributor.authorDoğan M.
dc.contributor.authorHacıbekiroğlu İ.
dc.date.accessioned2025-04-10T11:03:11Z
dc.date.available2025-04-10T11:03:11Z
dc.date.issued2023
dc.description.abstractFollowing publication of the original article [1], the authors reported an error in the author name of Enes Erul. Incorrect: Enes Urul Correct: Enes Erul, The original article [1] has been corrected. © 2023, The Author(s).
dc.identifier.DOI-ID10.1186/s12885-023-10662-3
dc.identifier.urihttp://hdl.handle.net/20.500.14701/44567
dc.publisherBioMed Central Ltd
dc.titleCorrection: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)
dc.typeErratum

Files